Kidney stone risk factors: Difference between revisions
No edit summary |
|||
(9 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
{{Kidney stone}} | {{Kidney stone}} | ||
{{CMG}}; {{AE}}{{ADS}} | |||
==Overview== | |||
Common risk factors in the development of nephrolithiasis include dietary habits, low urinary pH, [[hypercalcemia]], [[hypercalciuria]], [[hyperoxaluria]], [[hyperuricemia]], [[hyperuricosuria]], [[obesity]], [[diabetes mellitus]], environmental factors such as hot climate, drugs such as [[thiazide]], [[furosemide]], [[sulfadiazine]], [[indinavir]]. Less common risk factors in the development of nephrolithiasis include [[hypocitraturia]], beverage use, drugs like [[ciprofloxacin]] and [[triamterene]]. | |||
==Risk Factors== | |||
===Common Risk Factors=== | |||
*Common risk factors in the development of nephrolithiasis include:<ref name="pmid20811557">{{cite journal |vauthors=Romero V, Akpinar H, Assimos DG |title=Kidney stones: a global picture of prevalence, incidence, and associated risk factors |journal=Rev Urol |volume=12 |issue=2-3 |pages=e86–96 |date=2010 |pmid=20811557 |pmc=2931286 |doi= |url=}}</ref> | |||
**Dietary habits | |||
**Low urinary pH | |||
**[[Hypercalcemia]] | |||
**[[Hypercalciuria]] | |||
**[[Hyperoxaluria]] | |||
**[[Hyperuricemia]] | |||
**[[Hyperuricosuria]] | |||
**[[Metabolic syndrome]] | |||
**[[Obesity]] | |||
**[[Diabetes mellitus]] | |||
**Environmental - such as hot climate | |||
**Drugs<ref name="pmid16985842">{{cite journal |vauthors=Matlaga BR, Shah OD, Assimos DG |title=Drug-induced urinary calculi |journal=Rev Urol |volume=5 |issue=4 |pages=227–31 |date=2003 |pmid=16985842 |pmc=1508366 |doi= |url=}}</ref> | |||
***[[Thiazide]] | |||
***[[Furosemide]] | |||
***[[Sulfadiazine]] | |||
***[[Indinavir]] | |||
===Less Common Risk Factors=== | |||
*Less common risk factors in the development of nephrolithiasis include:<ref name="pmid20811557" /> | |||
**[[Hypocitraturia]] | |||
**Beverage use | |||
**Drugs<ref name="pmid16985842" /> | |||
***[[Ciprofloxacin]] | |||
***[[Triamterene]] | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: (name of the system)]] |
Latest revision as of 00:36, 22 June 2018
Kidney stone Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kidney stone risk factors On the Web |
American Roentgen Ray Society Images of Kidney stone risk factors |
Risk calculators and risk factors for Kidney stone risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Common risk factors in the development of nephrolithiasis include dietary habits, low urinary pH, hypercalcemia, hypercalciuria, hyperoxaluria, hyperuricemia, hyperuricosuria, obesity, diabetes mellitus, environmental factors such as hot climate, drugs such as thiazide, furosemide, sulfadiazine, indinavir. Less common risk factors in the development of nephrolithiasis include hypocitraturia, beverage use, drugs like ciprofloxacin and triamterene.
Risk Factors
Common Risk Factors
- Common risk factors in the development of nephrolithiasis include:[1]
- Dietary habits
- Low urinary pH
- Hypercalcemia
- Hypercalciuria
- Hyperoxaluria
- Hyperuricemia
- Hyperuricosuria
- Metabolic syndrome
- Obesity
- Diabetes mellitus
- Environmental - such as hot climate
- Drugs[2]
Less Common Risk Factors
- Less common risk factors in the development of nephrolithiasis include:[1]
- Hypocitraturia
- Beverage use
- Drugs[2]
References
- ↑ 1.0 1.1 Romero V, Akpinar H, Assimos DG (2010). "Kidney stones: a global picture of prevalence, incidence, and associated risk factors". Rev Urol. 12 (2–3): e86–96. PMC 2931286. PMID 20811557.
- ↑ 2.0 2.1 Matlaga BR, Shah OD, Assimos DG (2003). "Drug-induced urinary calculi". Rev Urol. 5 (4): 227–31. PMC 1508366. PMID 16985842.